Quantifying Syringe Exchange Program Operational Space in the District of Columbia

AIDS Behav. 2016 Dec;20(12):2933-2940. doi: 10.1007/s10461-016-1405-y.

Abstract

Syringe exchange programs (SEPs) are effective structural interventions for HIV prevention among persons who inject drugs. In 2000, a buffer zone policy (the 1000 Foot Rule) was implemented in Washington, DC, that prohibited SEP operations within 1000 feet of schools. We examined changes in the amount of legal SEP operational space over time. We used data pertaining to school operations and their approximate physical property boundaries to quantify the impact of the 1000 Foot Rule on legal SEP operational space from its implementation in 2000-2013. Adherence to the 1000 Foot Rule reduced SEP operational space by more than 50 % annually since its implementation. These findings demonstrate the significant restrictions on the amount of legal SEP operational space in Washington, DC, that are imposed by the 1000 Foot Rule. Changing this policy could have a significant impact on SEP service delivery among injectors.

Keywords: HIV; Health policy; Persons who inject drugs; Structural interventions; Syringe exchange programs.

MeSH terms

  • Delivery of Health Care / legislation & jurisprudence
  • Delivery of Health Care / organization & administration
  • District of Columbia
  • Facility Design and Construction / legislation & jurisprudence
  • Facility Regulation and Control / legislation & jurisprudence*
  • Female
  • HIV Infections / prevention & control*
  • HIV Infections / transmission*
  • Health Policy / legislation & jurisprudence
  • Health Services Accessibility / legislation & jurisprudence
  • Health Services Accessibility / organization & administration
  • Health Services Needs and Demand / legislation & jurisprudence
  • Health Services Needs and Demand / organization & administration
  • Humans
  • Male
  • Needle-Exchange Programs / legislation & jurisprudence*
  • Needle-Exchange Programs / organization & administration*
  • Schools*
  • Substance Abuse, Intravenous / epidemiology*